Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis

Tursi, Antonio; Elisei, Walter; Faggiani, Roberto; Allegretta, Leonardo; Della Valle, Nicola; Forti, Giacomo; Franceschi, Marilisa; Ferronato, Antonio; Gallina, Sara; Larussa, Tiziana; Luzza, Francesco; Lorenzetti, Roberto; Mocci, Giammarco; Penna, Antônio; Rodinò, Stefano; Sebkova, Ladislava; De Medici, Antonio; Pranzo, Giuseppe; Ricciardelli, C.; Grasso, Giuseppina; Scorza, Stefano; Zampaletta, Costantino; Picchio, Marcello

doi:10.1097/md.0000000000011897

Public

Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis

Published in Medicine • Aug 1, 2018

Authors:

Antonio Tursi

Walter Elisei

Roberto Faggiani

Abstract

Adalimumab (ADA) was approved in Italy for the treatment of ulcerative colitis (UC) unresponsive to standard treatments in 2014, but no data from real life are currently available. The aim of the present study was to assess the real-life efficacy and safety of ADA in managing UC outpatients in some ...

Subject

Medicine

Ulcerative colitis

Adalimumab

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!